A practical reference on LC-MS/MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-02-03. Anything still debated is marked as such rather than presented as settled.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| Molecular weight | 437.9 g/mol | Calculated from the formula |
| Primary target | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian regulation |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water |
| Typical storage | -20 °C, desiccated | Protect from light and moisture |
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
On April 7, 2021, The United States Navy guided missile destroyer USS John Paul Jones sailed through India's Exclusive Economic Zone, without New Delhi's prior consent, then publicly announced the event, causing a diplomatic spat. At a time when the United States and India had been deepening relations, such a move had raised eyebrows among the general public in both India and the United States. As per the official statement by the United States Navy's 7th Fleet, "On April 7, 2021 (local time) USS John Paul Jones (DDG 53) asserted navigational rights and freedoms approximately 130 nautical miles west of the Lakshadweep Islands, inside India's exclusive economic zone, without requesting India's prior consent, consistent with international law". India requires prior consent for military exercises or maneuvers in its exclusive economic zone or continental shelf, a claim inconsistent with international law. This freedom of navigation operation ("FONOP") upheld the rights, freedoms, and lawful uses of the sea recognized in international law by challenging India's excessive maritime claims. The Statement further added, "U.S. Forces operate in the Indo-Pacific region on a daily basis. All operations are designed in accordance with international law and demonstrate that the United States will fly, sail and operate wherever international law allows." The Pentagon defended the 7th Fleet's statement by claiming that the event was consistent with international law.
The toxicological cause of the disease has been attributed to the neurotoxin ODAP which acts as a structural analogue of the neurotransmitter glutamate. Lathyrism can also be caused by deliberate food adulteration.
==== Tryptophan and 5-HTP ==== The amino acid tryptophan is converted into 5-hydroxytryptophan (5-HTP) which is subsequently converted into the neurotransmitter serotonin. Since serotonin deficiency has been recognized as a possible cause of depression, it has been suggested that consumption of tryptophan or 5-HTP may therefore improve depression symptoms by increasing the level of serotonin in the brain. 5-HTP and tryptophan are sold over the counter in North America, but requires a prescription in Europe. The use of 5-HTP instead of tryptophan bypasses the conversion of tryptophan into 5-HTP by the enzyme tryptophan hydroxylase, which is the rate-limiting step in the synthesis of serotonin, and 5-HTP easily crosses the blood–brain barrier unlike tryptophan, which requires a transporter. Small studies have been performed using 5-HTP and tryptophan as adjunctive therapy in addition to standard treatment for depression. While some studies had positive results, they were criticized for having methodological flaws, and a more recent study did not find sustained benefit from their use. The safety of these medications has not been well studied. Due to the lack of high quality studies, preliminary nature of studies showing effectiveness, the lack of adequate study on their safety, and reports of eosinophilia–myalgia syndrome from contaminated tryptophan in 1989 and 1990, the use of tryptophan and 5-HTP is not highly recommended or thought to be clinically useful.
Entourage Guimard: Square-Victoria–OACI station on the Montreal Metro in Canada has a genuine Guimard entrance made from parts of demolished Paris entrances (with map holder and "Métropolitain" sign and holder reproduced from the original molds). It was installed in 1967. During restoration in 2001–2002, it was found to have the last examples of the original glass light globes, which in Paris had been replaced with plastic for safety; one was returned to the RATP and the other placed on display in the Montreal Museum of Fine Arts. Bellas Artes station on the Mexico City Metro in Mexico has a Guimard entrance installed in 1998. Picoas station on the Lisbon Metro in Portugal has a Guimard entrance installed in 1995. Kievskaya station on the Moscow Metro in Russia has a Guimard entrance installed in 2007. Van Buren Street station on the Metra Electric District in Chicago had a Guimard entrance installed in 2001. An Entrance to the Paris Métropolitain: The National Gallery of Art in Washington, D.C., United States has a Guimard entrance in its sculpture garden, first shown at the gallery in a 2000–2001 exhibition on Art Nouveau and permanently installed in the garden in 2003. The Museum of Modern Art in New York City, United States has the archway consisting of the light stalks and "Métropolitain" sign from the Guimard entrance to Raspail station. The Dali Theater Museum in Figueres (Girona, Spain) has a pair of the light stalks from a Guimard Métro entrance, which are exhibited on the patio.
=== Metalloproteins === Metalloproteins are conjugated proteins that are characterized by having one or more metal ions attached to the protein as a prosthetic groups. These metal ions could be iron, zinc, copper, magnesium, etc., and these are very important to the biological functions and its protein activity. Metalloproteins are involved in a wide range processes from electron transfer to catalysis. Many enzymes are metalloproteins, since metal ions can act as cofactors in chemical reactions. For example, zinc ions can be associated with enzymes that are responsible for gene expression. Moreover, metalloproteins containing iron often are involved in oxygen transport and redox reactions. In this way, the presence of metal ions allows these proteins to perform certain tasks that would not be possible with amino acids alone.
Sources: en.wikipedia.org
== Structural studies == As of late 2007, 15 structures have been solved for this class of enzymes, with PDB accession codes PDB: 1S5B, PDB: 1S5C, PDB: 1S5D, PDB: 1S5E, PDB: 1S5F, PDB: 1SGK, PDB: 1TOX, PDB: 1XDT, PDB: 1XK9, PDB: 1ZM3, PDB: 1ZM4, PDB: 1ZM9, PDB: 2A5D, PDB: 2A5F, and PDB: 2A5G.
{\displaystyle p_{u}={\begin{cases}{\dfrac {f_{u}}{\sum _{i=1}^{20}f_{i}\,+\,w\sum _{k=1}^{\lambda }\tau _{k}}},&(1\leq u\leq 20)\\[10pt]{\dfrac {w\tau _{u-20}}{\sum _{i=1}^{20}f_{i}\,+\,w\sum _{k=1}^{\lambda }\tau _{k}}},&(20+1\leq u\leq 20+\lambda )\end{cases}}\qquad {\text{(4)}}}
=== Mass average molar mass === The mass average molar mass (often loosely termed weight average molar mass) is another way of describing the molar mass of a polymer. Some properties are dependent on molecular size, so a larger molecule will have a larger contribution than a smaller molecule. The mass average molar mass is calculated by
=== Blueprint === On October 13, 2021, Johnson announced an anti-aging attempt called Project Blueprint, which subsequently became the basis for a commercial company headquartered in Los Angeles co-founded with Kate Tolo. Johnson has stated the aims of the company are to reduce the biological age of his organs to that of an 18-year-old and "make death an option." Blueprint sells consumer health products including supplements and foods derived from Johnson's personal optimization protocol. The protocol that Johnson follows as the test subject cost approximately $2 million a year in 2023, and was tracking over 100 health measurements. He has since reduced his daily supplement intake from 111 to 30 by March 2026. In 2024, Blueprint Basics was launched as a subscription for consumers by Blueprint, costing $333 a month. In October, Blueprint raised $60 million in external funding from a group of investors that included Kim Kardashian and Cameron & Tyler Winklevoss. In July 2025, Gyre Renwick was appointed as the CEO of Blueprint, having formerly served as president of Modern Health. Johnson would continue to lead product and protocol development.
Sources: en.wikipedia.org
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.
It binds to REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian and metabolic gene regulation. This can alter transcription of genes related to lipid and glucose metabolism in experimental models.
No controlled human trials have established that effect. Endurance findings come primarily from rodent studies, and human responses remain unknown.
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.